Alnylam Pharmaceuticals
ALNY
$188.70
Share price
-0.67%
Change (1 day)
16.73%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Operating Margin for Alnylam Pharmaceuticals (ALNY)
Operating Margin as of March 2023 (TTM): -100.93%
According to Alnylam Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -100.93%. At the end of 2021 the company had an Operating Margin of -100.93%.
Operating Margin history for Alnylam Pharmaceuticals from 2008 to 2012
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -100.93% | -41.86% |
| 2020 | -173.60% | -56.91% |
| 2019 | -402.85% | -60.33% |
| 2018 | -1,015.48% | 86% |
| 2017 | -545.95% | -37.22% |
| 2016 | -869.63% | 23.21% |
| 2015 | -705.83% | -10.92% |
| 2014 | -792.32% | 306.56% |
| 2013 | -194.88% | 11.54% |
| 2012 | -174.73% | 150.82% |
| 2011 | -69.66% | 62.06% |
| 2010 | -42.98% | -8.07% |
| 2009 | -46.76% | 76.12% |
| 2008 | -26.55% | -83.16% |
| 2007 | -157.61% | 7.45% |
| 2006 | -146.68% | -80.71% |
| 2005 | -760.53% | 0.84% |
| 2004 | -754.18% | -93.51% |
| 2003 | -11,618.18% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 16.15% | -116.00% | 🇨🇭 Switzerland |
 Sanofi SNY | 19.90% | -119.72% | 🇫🇷 France |
 Regeneron Pharmaceuticals REGN | 39.91% | -139.54% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -81.10% | -19.65% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | -118.00% | 16.91% | 🇺🇸 USA |
 OPKO Health
OPK | -29.10% | -71.17% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 4.14% | -104.10% | 🇮🇱 Israel |
 Arrowhead Pharmaceuticals
ARWR | -71.00% | -29.65% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.